It is now becoming generally recognized that microarray technology will be a fundamental tool used in future genomics research. As the technology becomes more widely accessible, larger numbers of ...

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...

The roots of Russia's invasion of Ukraine go back decades and run deep. The current conflict is more than one country fighting to take over another; it is — in the words of one U.S. official — a shift ...

This post contains spoilers for Severance. This article breaks down Severance Season 1's ending. If you're caught up through Season 2, check out our Severance Season 2 Ending Explained. In a world ...

Biotechnology instruments market size was valued at USD 92.12 billion in 2025 and is projected to hit the market valuation of USD 141.70 billion by 2035 at a CAGR of 4.4% during the forecast period ...

The Global Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from ...

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through ...

胃肠道恶性肿瘤长期位居全球发病与死亡负担的前列。尽管影像学技术、内镜评估和基因检测不断进步，但在胆管癌、胰腺癌、胃癌和食管腺癌等疾病中，早期诊断依然困难，导致多数患者在进展期才被发现，错失最佳干预窗口。尤其对于高度异质性肿瘤，如结直肠癌和胆管癌，病理诊断仍是关键环节，但受限于活检组织量有限、肿瘤分化 ...